VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions
2016 ◽
Vol 44
(8)
◽
pp. 1286-1295
◽
Keyword(s):
2019 ◽
Vol 59
(6)
◽
pp. 781-808
◽
2020 ◽
Vol 48
(10)
◽
pp. 1028-1043
◽
Keyword(s):
2012 ◽
Vol 40
(7)
◽
pp. 1336-1344
◽
2020 ◽
Vol 376
(1)
◽
pp. 64-73
2018 ◽
Vol 123
(6)
◽
pp. 739-748
◽
2009 ◽
Vol 24
(6)
◽
pp. 500-510
◽
Keyword(s):
2018 ◽
Vol 15
(5)
◽
pp. 1979-1995
◽
Keyword(s):